TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer

Abstract Background In non-small cell lung cancer (NSCLC) the efficacy of chemo-immunotherapy is affected by the high expression of drug efflux transporters as ABCC1 and by the low expression of ABCA1, mediating the isopentenyl pyrophosphate (IPP)-dependent anti-tumor activation of Vγ9Vδ2 T-lymphocy...

Descripció completa

Dades bibliogràfiques

Autors principals:	Muhlis Akman, Ciro Monteleone, Gabriella Doronzo, Martina Godel, Francesca Napoli, Alessandra Merlini, Virginia Campani, Valeria Nele, Elisa Balmas, Tatiana Chontorotzea, Simona Fontana, Sabrina Digiovanni, Francesca Alice Barbu, Elena Astanina, Niloufar Jafari, Iris Chiara Salaroglio, Joanna Kopecka, Giuseppe De Rosa, Thomas Mohr, Alessandro Bertero, Luisella Righi, Silvia Novello, Giorgio Vittorio Scagliotti, Federico Bussolino, Chiara Riganti
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2024-08-01
Col·lecció:	Journal of Experimental & Clinical Cancer Research
Matèries:	TFEB Chemo-immuno-resistance ABCC1 ABCA1 Vγ9Vδ2 T-lymphocytes Non-small cell lung cancer
Accés en línia:	https://doi.org/10.1186/s13046-024-03142-4
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!